Sentences with phrase «price growth by»

According to a new report, the changes could slow home price growth by as much as 4 percent.

According to a report from Moody's Analytics, the changes could slow home price growth by as much as 4 percent by 2019.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

By contrast, while the cost of older, branded pharmaceuticals continue to rise and contribute to increased spending, when discounting is considered, prices of these drugs increased, on average, 2.8 % in 2015, the lowest growth rate in years.

Roughly 80 % of the spending growth on these patent - protected drugs was offset by rebates and price concessions.

Investors may have priced in Snapchat's slowing user growth, which was reported early in 2017 and later confirmed by the company's S - 1.

«What this shows is that increased competition among manufacturers, the aggressive negotiations by pharmacy benefits managers, and to some extent the significant public discussion about drug pricing and prices have all contributed to a relatively modest level of growth in 2015,» says Murray Aitken, Executive Director of the IMS Institute.

In 2015, revenue for the 500 largest global corporations dropped 11.5 % to $ 27.6 trillion, owing to falling oil prices and in part by the surge in value of the U.S. dollar, which has stalled economic growth worldwide.

While gold is often considered an inflation hedge, Julius Baer said in a note, the fact that price pressures were being driven by confidence about growth rather than dollar weakness and rising oil prices meant it was failing to react positively.

The bank cited the prospect of slower economic growth in Canada brought about by lower oil prices as one reason for moderating the rate.

That's massive growth, no matter how you look at it, which helped push the stock price (NFLX) up by more than 139 % last year.

Still, the Fed chairman reiterated his argument that lower rates boost growth by helping increase prices of stocks, homes and other assets.

Some of the possible excess in house prices could in the interval be tempered by factors such as income growth, regulatory changes and modest price corrections along the way.

The revenue growth was driven by favorable price and high - teens growth in electronics, which offset the impact of order choppiness.

The organic growth was driven by strong volume across most products and geographies along with solid price realization.

Meanwhile, the Labor Department is expected to report that U.S. producer prices rose 0.3 % last month, which is slightly higher than the previous month's growth, and the consumer price index also likely improved by 0.3 % in May.

By contrast, economic growth in Canada contracted in the first half of the year and business investment — the most important factor in demand for imports — collapsed along with oil prices.

The value of Australian iron ore exports is expected to fall next year as strong growth in production volumes is offset by a slump in prices to a forecast $ US52.10 per tonne in 2016.

«Shell's strong earnings this quarter were underpinned by higher oil and gas prices, the continued growth and very good performance of our Integrated Gas business, and improved profitability in our Upstream business,» Chief Executive Officer Ben van Beurden said in a statement.

Many commentators go on to conclude that the higher incomes generated by high commodity prices have given Canadians a temporary reprieve from the problem of low productivity growth.

«Overall, annual house price growth nationally is most likely expected to slow to 1 - 4 % by the end of 2017.

Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.

It says the economy, hit hard by low oil prices, will benefit from the growth of an entertainment industry.

Another Principal fund, the $ 7.5 billion Principal LargeCap Growth I fund managed by T. Rowe Price, marked down its Uber stake by about another 8 %, a total reduction of more than 12 % since April.

More than two dozen domestic solar mounting equipment manufacturers and their domestic suppliers told the ITC, in a letter sent in August, that the tariffs requested by Suniva would more than double the price of solar panels in the U.S. and undercut the cost - competitiveness of solar and reversing its high growth trajectory.

In the October report, there were five: stronger - than - expected U.S. growth; higher - than - expected oil prices; the possibility that weak business investment had altered the economy's potential; slower growth in less advanced economies such as China; and a tilt to saving from spending by Canada's heavily indebted households.

The reports looked strong at first, but looking under the hood, Cramer was very concerned by the weakness he saw: Kimberly - Clark, for one, is facing pricing challenges, rising commodity costs and a slumping diaper business in what had once been its best growth market: China.

Failure of prices to recover raises the prospect of even deeper cuts to investment by oil and gas companies next year and would likely result in Canada's economy remaining on a slower growth path than the 2.2 per cent pace we are expecting.»

The global growth hasn't rolled out as fast as investors had hoped, resulting in some recent yo - yoing of Netflix's stock price — but some analysts think the company could still double its customer base by 2020.

Slower economic growth has been partially masked by rising asset prices and the wealth effect.

Meanwhile, margins of its more complex, specialty products, the group's designated growth drivers, have been squeezed by higher raw materials prices.

Meanwhile, cable revenue was $ 872 million, up from $ 870 million a year ago, as continued Internet revenue growth and the pricing changes across all product types was mostly offset by television subscriber losses.

The price growth is driven primarily by companies in the energy and technology industries, according to Reis.

«By limiting our price increases to the NHE growth projection, we ensure that Sanofi is not contributing to further medical inflation,» he said.

LONDON, May 1 - BP's profits surged in the first three months of the year to their highest since mid-2014, driven by a recovery in oil and gas prices and rapid growth in production.

During his tenure with AlliedSignal, the company achieved consistent growth in earnings and cash flow, highlighted by 31 consecutive quarters of earnings - per - share growth of 13 % or more and an eight-fold appreciation of the company's share price.

The tariffs will be felt most heavily by workers and consumers in the United States as the «collateral damage» spreads throughout the American economy in the form of higher prices and stunted growth, said Jean Simard, head of the Aluminium Association of Canada.

«In line with the 2013 norm,» June price growth was driven by single - detached and semi-detached houses, particularly in the city of Toronto, the board said in a report Thursday.

However, the Pan Canadian Framework on Clean Growth and Climate Change lays out a number of policies that will compel more clean tech innovation in Canada, he said, including a price on pollution with a carbon price, to be in place across Canada by the start of next year, as well as a promised national clean fuels strategy, better energy efficiency standards and limits on greenhouse gases like methane.

Fueled by a surge of renters across all age ranges, rental prices nationally have grown at roughly twice the pace of average hourly wage growth, which was a paltry 2.1 percent over the past year.

Generally, strong demand for copper (evidenced by rising prices) suggests global growth, while the reverse may foreshadow slowdown.

This, after a year of flatter growth and considerable volatility in the commodity markets, marked by continued discounts on Canadian crude and low gas prices.

Said Poloz: «That comparative advantage has been strengthened by the decline in the Canadian dollar in the past couple of years — a symptom of falling resource prices, and a facilitator of the rotation of growth from resource production to other sectors.»

As Business Insider's Sam Ro wrote: «Golub believes 2015, as in 2014, will be highlighted by healthy US GDP growth, lackluster global growth with China and Japan getting worse, elevated profit margins, low volatility, and most multiple expansion, that is higher price / earnings (P / E) multiples.

Fuel prices have been in a downtrend since June, losing nearly 50 percent of their value, on the back of a price war waged by OPEC (the Organization of Petroleum Exporting Countries) against the U.S. shale producers and as demand from China decreased amid slowing growth.

«I believe we are in for much greater volatility in oil prices for the foreseeable future and that's why you've seen Cenovus preserve cash by moderating our growth and reducing our workforce,» CEO Brian Ferguson said in announcing the job cuts.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

«We believe the bias for stock prices in general remains to the upside, underpinned by a growing economy, low interest rates and increasingly, cheaper oil... With operating margins at elevated levels, top line growth is poised to more quickly bleed through to the bottom line, thus supporting earnings.»

The report added: «The growth in this market is more robust, driven by increases in volumes rather than prices.»

Kimberly said its results were hurt by commodity price inflation but it is pleased with an increase in organic growth.